La catena delle opzioni mostra i dati chiave delle opzioni azionarie di NextPlay Technologies a vari prezzi di esercizio e date di scadenza. I trader utilizzano queste informazioni per analizzare potenziali operazioni e valutare il sentiment del mercato per NextPlay Technologies..

NextPlay Technologies (OTC:NXTP) Azioni, Catena delle Opzioni

NextPlay Technologies

NextPlay Technologies Inc is building a technology solutions company, offering games, in-game advertising, digital asset products and services, connected TV and travel booking services to consumers and corporations within a growing digital ecosystem. Its engaging products and services utilize advertising technology, Artificial Intelligence, and financial technology (FinTech) solutions to leverage the strengths and channels of its existing and acquired technologies. NextPlay is organized into 3 divisions NextMedia, its Interactive Digital Media Division (the Media Division); NextFinTech, its Finance and Technology (FinTech) Division; and NextTrip, its Travel Division.

NEXTPLAY TECHS INC by NextPlay Technologies, Inc.

NextPlay Technologies Inc

WIIM

Samsara shares are trading lower. The company reported Q3 financial results.

<p>Cyclacel Pharmaceuticals, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CYCC#NASDAQ">CYCC</a>, NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CYCCP#NASDAQ">CYCCP</a>, ", Cyclacel", or the ", Company", ))), a biopharmaceutical company developing innovative cancer medicines, today announced that it is in the process of exploring and reviewing strategic alternatives on an expedited basis in order to preserve the Company's cash, including a potential transaction with investor David Lazar of Activist Investing, LLC, which transaction would be subject to the consent of an existing securityholder.</p>
<p>The Company's Board of Directors is reviewing a range of appropriate strategies to realize value from its assets. The Board has directed management to reduce operating costs while such alternatives are being explored. There can be no assurance that the exploration of strategic alternatives will result in any agreement or transaction, or as to the timing of any such agreement or transaction. Further, there can be no assurance that the Company will be able to reach an agreement, or consummate a transaction, with Mr. Lazar or receive the required consent of an existing securityholder to any such transaction.</p>
<p>As previously disclosed, the Company does not presently meet the continued listing requirements of the Nasdaq Stock Market and its securities would be subject to delisting if the Company fails to regain compliance during the required compliance period. In the event that the Company is not able to enter into a strategic transaction and/or secure additional funding, it may be forced to cease all business operations. In such event, the Company's stockholders may lose a part or all of their investment in the Company.</p>


News

CYCC

CYCCP

Cyclacel Pharmaceuticals Announces Its Exploration Of Potential Strategic Alternatives On An Expedited Basis In Order To Preserve The Company's Cash, Including A Potential Transaction With Investor David Lazar Of Activist Investing, LLC

<p>The Q3 earnings report for <strong>Petco Health and Wellness</strong> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WOOF#NASDAQ">WOOF</a>) was released on Thursday, December 5, 2024 at 04:02 PM.</p>
<p>Here's what investors need to know about the latest announcement.</p>
<h3>Earnings</h3>
<p>Petco Health and Wellness beat estimated earnings by 50.0%, reporting an EPS of $-0.02 versus an estimate of $-0.04.</p>
<p>Revenue was up $17.00 million from the same period last year.</p>
<h3>Earnings History Overview</h3>
<p>Last quarter the company missed on EPS by $0.0 which was followed by a 33.0% increase in the share price the next day.</p>
<p>Here's a look at Petco Health and Wellness's past performance:</p>
<p>
<table>
<thead>
<tr>
<th><strong>Quarter</strong></th>
<th><strong>Q2 2024</strong></th>
<th><strong>Q1 2024</strong></th>
<th><strong>Q4 2023</strong></th>
<th><strong>Q3 2023</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>EPS Estimate</strong></td>
<td>-0.02</td>
<td>-0.07</td>
<td>0.02</td>
<td>0.02</td>
</tr>
<tr>
<td><strong>EPS Actual</strong></td>
<td>-0.02</td>
<td>-0.04</td>
<td>0.02</td>
<td>-0.05</td>
</tr>
<tr>
<td><strong>Revenue Estimate</strong></td>
<td>1.52B</td>
<td>1.51B</td>
<td>1.62B</td>
<td>1.51B</td>
</tr>
<tr>
<td><strong>Revenue Actual</strong></td>
<td>1.52B</td>
<td>1.53B</td>
<td>1.67B</td>
<td>1.49B</td>
</tr>
</tbody>
</table>
</p>
<p>New investors should note that it is sometimes not an earnings beat or miss that most affects the price of a stock, but the guidance (or forecast).</p>
<h3>Guidance</h3>
<p>Petco Health and Wellness management provided guidance for Q4 2024, expecting earnings between $0.0 and $0.02 per share.</p>
<p>To track all earnings releases for Petco Health and Wellness <a href="https://www.benzinga.com/quote/WOOF/earnings">visit their earnings calendar here.</a> </p>
<p>This article was generated by Benzinga's automated content engine and reviewed by an editor.</p>


Earnings

WOOF

Petco Health and Wellness Q3 Earnings Assessment

LPTH

LightPath Technologies Unveils Optical Gas Imaging Camera For Detecting Ammonia And SF6 Emissions, Offering Non-Germanium Solution Amid China's Export Ban To The U.S.

<p>The earnings results for <strong>HashiCorp</strong> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HCP#NASDAQ">HCP</a>) for Q3 were made public on Thursday, December 5, 2024 at 04:05 PM.</p>
<p>Here's a comprehensive overview of the announcement.</p>
<h3>Earnings</h3>
<p>HashiCorp beat estimated earnings by 160.0%, reporting an EPS of $0.13 versus an estimate of $0.05.</p>
<p>Revenue was up $27.26 million from the same period last year.</p>
<h3>Previous Earnings Records</h3>
<p>Last quarter the company beat on EPS by $0.08 which was followed by a 0.0% increase in the share price the next day.</p>
<p>Here's a look at HashiCorp's past performance:</p>
<p>
<table>
<thead>
<tr>
<th><strong>Quarter</strong></th>
<th><strong>Q2 2025</strong></th>
<th><strong>Q1 2025</strong></th>
<th><strong>Q4 2024</strong></th>
<th><strong>Q3 2024</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>EPS Estimate</strong></td>
<td>0</td>
<td>-0.01</td>
<td>0.01</td>
<td>-0.04</td>
</tr>
<tr>
<td><strong>EPS Actual</strong></td>
<td>0.08</td>
<td>0.05</td>
<td>0.05</td>
<td>0.03</td>
</tr>
<tr>
<td><strong>Revenue Estimate</strong></td>
<td>157.25M</td>
<td>153.19M</td>
<td>149.29M</td>
<td>143.24M</td>
</tr>
<tr>
<td><strong>Revenue Actual</strong></td>
<td>165.14M</td>
<td>160.58M</td>
<td>155.78M</td>
<td>146.12M</td>
</tr>
</tbody>
</table>
</p>
<p>To track all earnings releases for HashiCorp <a href="https://www.benzinga.com/quote/HCP/earnings">visit their earnings calendar here.</a> </p>
<p>This article was generated by Benzinga's automated content engine and reviewed by an editor.</p>


Recap: HashiCorp Q3 Earnings

<p>The Q3 earnings report for <strong>Argan</strong> (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AGX#NYSE">AGX</a>) was released on Thursday, December 5, 2024 at 04:05 PM.</p>
<p>Here's what investors need to know about the latest announcement.</p>
<h3>Earnings</h3>
<p>Argan beat estimated earnings by 59.0%, reporting an EPS of $2.0 versus an estimate of $1.26.</p>
<p>Revenue was up $93.25 million from the same period last year.</p>
<h3>Analysis of Past Earnings</h3>
<p>The company beat on EPS by $0.34 in the previous quarter, leading to a 26.0% increase share price change the next day.</p>
<p>Here's a look at Argan's past performance:</p>
<p>
<table>
<thead>
<tr>
<th><strong>Quarter</strong></th>
<th><strong>Q2 2024</strong></th>
<th><strong>Q1 2024</strong></th>
<th><strong>Q4 2023</strong></th>
<th><strong>Q3 2023</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>EPS Estimate</strong></td>
<td>0.97</td>
<td>0.52</td>
<td>0.75</td>
<td>0.88</td>
</tr>
<tr>
<td><strong>EPS Actual</strong></td>
<td>1.31</td>
<td>0.58</td>
<td>0.89</td>
<td>0.40</td>
</tr>
<tr>
<td><strong>Revenue Estimate</strong></td>
<td>183.55M</td>
<td>134.75M</td>
<td>161.60M</td>
<td>162.70M</td>
</tr>
<tr>
<td><strong>Revenue Actual</strong></td>
<td>227.01M</td>
<td>157.68M</td>
<td>164.55M</td>
<td>163.75M</td>
</tr>
</tbody>
</table>
</p>
<p>To track all earnings releases for Argan <a href="https://www.benzinga.com/quote/AGX/earnings">visit their earnings calendar here.</a> </p>
<p>This article was generated by Benzinga's automated content engine and reviewed by an editor.</p>


Insights into Argan Q3 Earnings

Hewlett-Packard shares are trading higher after the company reported better-than-expected Q4 financial results.

GWRE

Guidewire Software shares are trading lower. The company reported Q1 financial results.

RKLB

Rocket Lab Announces December 18 Launch Window For Sixth Synspective Mission, Deploying StriX Satellite As Part Of 16-Launch Agreement Supporting Japanese Earth Observation Constellation

<p>Utz Brands, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/UTZ#NYSE">UTZ</a>) ("Utz" or the "Company"), a leading U.S. manufacturer of branded salty snacks and a small-cap value and growth Staples equity, today announced that its Board of Directors has approved an annual dividend increase from $0.236(1) to $0.244 per share. The increase is effective as of today, and the Utz Board of Directors has declared a regular quarterly cash dividend of approximately $0.061 per share on the Company's Class A Common Stock. Payment is expected to be made by the Company on January 2, 2025, to stockholders of record at the close of business on December 16, 2024.</p>


Dividends

Utz Brands Approved An Annual Dividend Increase From $0.236 To $0.244 Per Share

GTLB

GitLab shares are trading higher after the company reported better-than-expected Q3 financial results and issued Q4 guidance above estimates.

Guidance

VEEV

CORRECTION: Veeva Systems Sees Q4 2025 Adj. EPS ~$1.57; Revenue $696M-$699M

Chevron Announces $15B Organic Capex And $2B Affiliate Capex Budget For 2025, A $2B YoY Reduction; 4Q24 Restructuring Charges Estimated At $1.1B-$1.5B Amid Plans For $2B-$3B Cost Cuts By 2026; Focus Remains On Lower-Carbon Projects And Free Cash Flow Growth

<p>Duckhorn Portfolio (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NAPA#NYSE">NAPA</a>) reported quarterly earnings of $0.16 per share which met the analyst consensus estimate. This is a 6.67 percent increase over earnings of $0.15 per share from the same period last year.  The company reported quarterly sales of $122.94 million which missed the analyst consensus estimate of $127.98 million by 3.94 percent.  This is a 19.93 percent increase over sales of $102.51 million the same period last year.</p>


Earnings Misses

NAPA

Duckhorn Portfolio Q1 Adj $0.16, Inline, Sales $122.94M Miss $127.98M Estimate

<p><strong>Petco Health and Wellness</strong> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WOOF#NASDAQ">WOOF</a>) announced its Q3 earnings on Thursday, December 5, 2024 at 04:02 PM.</p>
<p>Here's a breakdown of the earnings report.</p>
<h3>Earnings</h3>
<p>Petco Health and Wellness beat estimated earnings by 50.0%, reporting an EPS of $-0.02 versus an estimate of $-0.04.</p>
<p>Revenue was up $17.00 million from the same period last year.</p>
<h3>Analysis of Past Earnings</h3>
<p>Last quarter the company missed on EPS by $0.0 which was followed by a 33.0% increase in the share price the next day.</p>
<p>Here's a look at Petco Health and Wellness's past performance:</p>
<p>
<table>
<thead>
<tr>
<th><strong>Quarter</strong></th>
<th><strong>Q2 2024</strong></th>
<th><strong>Q1 2024</strong></th>
<th><strong>Q4 2023</strong></th>
<th><strong>Q3 2023</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>EPS Estimate</strong></td>
<td>-0.02</td>
<td>-0.07</td>
<td>0.02</td>
<td>0.02</td>
</tr>
<tr>
<td><strong>EPS Actual</strong></td>
<td>-0.02</td>
<td>-0.04</td>
<td>0.02</td>
<td>-0.05</td>
</tr>
<tr>
<td><strong>Revenue Estimate</strong></td>
<td>1.52B</td>
<td>1.51B</td>
<td>1.62B</td>
<td>1.51B</td>
</tr>
<tr>
<td><strong>Revenue Actual</strong></td>
<td>1.52B</td>
<td>1.53B</td>
<td>1.67B</td>
<td>1.49B</td>
</tr>
</tbody>
</table>
</p>
<p>New investors should note that it is sometimes not an earnings beat or miss that most affects the price of a stock, but the guidance (or forecast).</p>
<h3>Guidance</h3>
<p>Petco Health and Wellness management provided guidance for Q4 2024, expecting earnings between $0.0 and $0.02 per share.</p>
<p>To track all earnings releases for Petco Health and Wellness <a href="https://www.benzinga.com/quote/WOOF/earnings">visit their earnings calendar here.</a> </p>
<p>This article was generated by Benzinga's automated content engine and reviewed by an editor.</p>


Earnings Breakdown: Petco Health and Wellness Q3

<p><strong>HashiCorp</strong> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HCP#NASDAQ">HCP</a>) reported its Q3 earnings results on Thursday, December 5, 2024 at 04:05 PM.</p>
<p>Here's what investors need to know about the announcement.</p>
<h3>Earnings</h3>
<p>HashiCorp beat estimated earnings by 160.0%, reporting an EPS of $0.13 versus an estimate of $0.05.</p>
<p>Revenue was up $27.26 million from the same period last year.</p>
<h3>Performance in Previous Earnings</h3>
<p>Last quarter the company beat on EPS by $0.08 which was followed by a 0.0% increase in the share price the next day.</p>
<p>Here's a look at HashiCorp's past performance:</p>
<p>
<table>
<thead>
<tr>
<th><strong>Quarter</strong></th>
<th><strong>Q2 2025</strong></th>
<th><strong>Q1 2025</strong></th>
<th><strong>Q4 2024</strong></th>
<th><strong>Q3 2024</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>EPS Estimate</strong></td>
<td>0</td>
<td>-0.01</td>
<td>0.01</td>
<td>-0.04</td>
</tr>
<tr>
<td><strong>EPS Actual</strong></td>
<td>0.08</td>
<td>0.05</td>
<td>0.05</td>
<td>0.03</td>
</tr>
<tr>
<td><strong>Revenue Estimate</strong></td>
<td>157.25M</td>
<td>153.19M</td>
<td>149.29M</td>
<td>143.24M</td>
</tr>
<tr>
<td><strong>Revenue Actual</strong></td>
<td>165.14M</td>
<td>160.58M</td>
<td>155.78M</td>
<td>146.12M</td>
</tr>
</tbody>
</table>
</p>
<p>To track all earnings releases for HashiCorp <a href="https://www.benzinga.com/quote/HCP/earnings">visit their earnings calendar here.</a> </p>
<p>This article was generated by Benzinga's automated content engine and reviewed by an editor.</p>


HashiCorp Earnings Review: Q3 Summary

<p><strong>Asana</strong> (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ASAN#NYSE">ASAN</a>) reported its Q3 earnings results on Thursday, December 5, 2024 at 04:05 PM.</p>
<p>Here's what investors need to know about the announcement.</p>
<h3>Earnings</h3>
<p>Asana beat estimated earnings by 71.0%, reporting an EPS of $-0.02 versus an estimate of $-0.07.</p>
<p>Revenue was up $17.38 million from the same period last year.</p>
<h3>Overview of Past Earnings</h3>
<p>In the previous quarter, the company beat on EPS by $0.03, resulting in a 5.0% drop change in the share price the following day.</p>
<p>Here's a look at Asana's past performance:</p>
<p>
<table>
<thead>
<tr>
<th><strong>Quarter</strong></th>
<th><strong>Q2 2024</strong></th>
<th><strong>Q1 2024</strong></th>
<th><strong>Q4 2023</strong></th>
<th><strong>Q3 2023</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>EPS Estimate</strong></td>
<td>-0.08</td>
<td>-0.08</td>
<td>-0.10</td>
<td>-0.11</td>
</tr>
<tr>
<td><strong>EPS Actual</strong></td>
<td>-0.05</td>
<td>-0.06</td>
<td>-0.04</td>
<td>-0.04</td>
</tr>
<tr>
<td><strong>Revenue Estimate</strong></td>
<td>177.65M</td>
<td>168.73M</td>
<td>167.68M</td>
<td>164.14M</td>
</tr>
<tr>
<td><strong>Revenue Actual</strong></td>
<td>179.21M</td>
<td>172.45M</td>
<td>171.13M</td>
<td>166.50M</td>
</tr>
</tbody>
</table>
</p>
<p>To track all earnings releases for Asana <a href="https://www.benzinga.com/quote/ASAN/earnings">visit their earnings calendar here.</a> </p>
<p>This article was generated by Benzinga's automated content engine and reviewed by an editor.</p>


ASAN

Asana Earnings Review: Q3 Summary

<p><strong>Tilly's</strong> (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TLYS#NYSE">TLYS</a>) just disclosed its Q3 earnings on Thursday, December 5, 2024 at 04:05 PM.</p>
<p>Here's a brief overview of the earnings report.</p>
<h3>Earnings</h3>
<p>Tilly's missed estimated earnings by -34.0%, reporting an EPS of $-0.43 versus an estimate of $-0.32.</p>
<p>Revenue was down $23.03 million from the same period last year.</p>
<h3>Past Earnings Performance</h3>
<p>During the previous quarter, the company beat on EPS by $0.09, leading to a 4.0% drop share price change the next day.</p>
<p>Here's a look at Tilly's's past performance:</p>
<p>
<table>
<thead>
<tr>
<th><strong>Quarter</strong></th>
<th><strong>Q2 2024</strong></th>
<th><strong>Q1 2024</strong></th>
<th><strong>Q4 2023</strong></th>
<th><strong>Q3 2023</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>EPS Estimate</strong></td>
<td>-0.09</td>
<td>-0.47</td>
<td>-0.22</td>
<td>-0.07</td>
</tr>
<tr>
<td><strong>EPS Actual</strong></td>
<td>0</td>
<td>-0.48</td>
<td>-0.17</td>
<td>-0.03</td>
</tr>
<tr>
<td><strong>Revenue Estimate</strong></td>
<td>163.81M</td>
<td>115.16M</td>
<td>171.65M</td>
<td>167.98M</td>
</tr>
<tr>
<td><strong>Revenue Actual</strong></td>
<td>162.87M</td>
<td>115.86M</td>
<td>173.02M</td>
<td>166.47M</td>
</tr>
</tbody>
</table>
</p>
<p>New investors should note that it is sometimes not an earnings beat or miss that most affects the price of a stock, but the guidance (or forecast).</p>
<h3>Guidance</h3>
<p>Tilly's management provided guidance for Q4 2024, expecting earnings between $-0.43 and $-0.32 per share.</p>
<p>To track all earnings releases for Tilly's <a href="https://www.benzinga.com/quote/TLYS/earnings">visit their earnings calendar here.</a> </p>
<p>This article was generated by Benzinga's automated content engine and reviewed by an editor.</p>


TLYS

Tilly's Earnings Review: Q3 Summary

<p><strong>Zumiez</strong> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ZUMZ#NASDAQ">ZUMZ</a>) announced its Q3 earnings on Thursday, December 5, 2024 at 04:05 PM.</p>
<p>Here's a breakdown of the earnings report.</p>
<h3>Earnings</h3>
<p>Zumiez beat estimated earnings by 100.0%, reporting an EPS of $0.06 versus an estimate of $0.03.</p>
<p>Revenue was up $6.14 million from the same period last year.</p>
<h3>Past Earnings Performance</h3>
<p>The company beat on EPS by $0.29 in the previous quarter, leading to a 4.0% increase share price change the next day.</p>
<p>Here's a look at Zumiez's past performance:</p>
<p>
<table>
<thead>
<tr>
<th><strong>Quarter</strong></th>
<th><strong>Q2 2024</strong></th>
<th><strong>Q1 2024</strong></th>
<th><strong>Q4 2023</strong></th>
<th><strong>Q3 2023</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>EPS Estimate</strong></td>
<td>-0.33</td>
<td>-1.14</td>
<td>0.26</td>
<td>-0.18</td>
</tr>
<tr>
<td><strong>EPS Actual</strong></td>
<td>-0.04</td>
<td>-0.86</td>
<td>0.40</td>
<td>-0.12</td>
</tr>
<tr>
<td><strong>Revenue Estimate</strong></td>
<td>201.96M</td>
<td>171.40M</td>
<td>275.87M</td>
<td>213.58M</td>
</tr>
<tr>
<td><strong>Revenue Actual</strong></td>
<td>210.18M</td>
<td>177.39M</td>
<td>281.82M</td>
<td>216.34M</td>
</tr>
</tbody>
</table>
</p>
<p>To track all earnings releases for Zumiez <a href="https://www.benzinga.com/quote/ZUMZ/earnings">visit their earnings calendar here.</a> </p>
<p>This article was generated by Benzinga's automated content engine and reviewed by an editor.</p>


ZUMZ

Zumiez Q3 Earnings Assessment

<p>The earnings results for <strong>GitLab</strong> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GTLB#NASDAQ">GTLB</a>) for Q3 were made public on Thursday, December 5, 2024 at 04:06 PM.</p>
<p>Here's a comprehensive overview of the announcement.</p>
<h3>Earnings</h3>
<p>GitLab beat estimated earnings by 44.0%, reporting an EPS of $0.23 versus an estimate of $0.16.</p>
<p>Revenue was up $46.38 million from the same period last year.</p>
<h3>Overview of Past Earnings</h3>
<p>The company beat on EPS by $0.05 in the last quarter, resulting in a 22.0% increase share price change the following day.</p>
<p>Here's a look at GitLab's past performance:</p>
<p>
<table>
<thead>
<tr>
<th><strong>Quarter</strong></th>
<th><strong>Q2 2025</strong></th>
<th><strong>Q1 2025</strong></th>
<th><strong>Q4 2024</strong></th>
<th><strong>Q3 2024</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>EPS Estimate</strong></td>
<td>0.10</td>
<td>-0.04</td>
<td>0.08</td>
<td>-0.01</td>
</tr>
<tr>
<td><strong>EPS Actual</strong></td>
<td>0.15</td>
<td>0.03</td>
<td>0.15</td>
<td>0.09</td>
</tr>
<tr>
<td><strong>Revenue Estimate</strong></td>
<td>176.89M</td>
<td>165.89M</td>
<td>158.21M</td>
<td>141.49M</td>
</tr>
<tr>
<td><strong>Revenue Actual</strong></td>
<td>182.58M</td>
<td>169.19M</td>
<td>163.78M</td>
<td>149.67M</td>
</tr>
</tbody>
</table>
</p>
<p>New investors should note that it is sometimes not an earnings beat or miss that most affects the price of a stock, but the guidance (or forecast).</p>
<h3>Guidance</h3>
<p>GitLab management provided guidance for Q4 2025, expecting earnings between $0.22 and $0.23 per share.</p>
<p>To track all earnings releases for GitLab <a href="https://www.benzinga.com/quote/GTLB/earnings">visit their earnings calendar here.</a> </p>
<p>This article was generated by Benzinga's automated content engine and reviewed by an editor.</p>


GitLab Q3 Earnings Assessment

Overall market sentiment has been high on Nextplay Technologies Inc (NXTP)  stock lately. NXTP receives a Bullish rating from InvestorsObserver Stock Sentiment Indicator. Nextplay Technologies Inc has a Bullish sentiment reading. Find out what this means for you and get the rest of the rankings on NXTP!See Full NXTP Report

Is it Time to Dump Nextplay Technologies Inc (NXTP) Stock After it Is Up 12.16% in a Week?

HWH, BFRG and NXTP among pre-market losers

These Technology stocks are trading higher:-SurgePays (SURGW) stock is trading at $2.38, a gain of $0.57, or 31.5%, on moderate volume.  Surgepays Inc WT gets a Sentiment Score of Bearish from InvestorsObserver.  -Baijiayun Group Ltd (RTC) stock is trading at $7.22, a rise of $1.32, or 24.07%, on high volume.  Baijiayun Gr

Technology Stocks Moving Up and Down Monday: SURGW, RTC, FTFT, BTDR, NXTP, GCT, MOB, LNVGY

Nextplay Technologies Inc (NXTP) stock has fallen -57.95% over the last 12 months. InvestorsObserverâ€&#x2122;s proprietary ranking system, gives NXTP stock a score of  21 out of a possible 100. That rank is  influenced by a short-term technical score of 26. NXTP's rank also includes a long-term technical score of 38.  NXTP has an

Is Nextplay Technologies Inc (NXTP) Stock a Smart Investment Wednesday?

A rating of 17 puts Nextplay Technologies Inc (NXTP) near the top of the Technology sector according to InvestorsObserver.Nextplay Technologies Inc's score of 17 means that it ranks higher than 17% of stocks in the sector. In addition, its overall score of 34 ranks it higher than 34% of all stocks. NXTP has an Overall Scor

Will Nextplay Technologies Inc (NXTP) Lag the Rest of the Stocks in the Technology Sector?

Nextplay Technologies Inc (NXTP) stock is down -55.51% over the last 12 months. InvestorsObserver's proprietary ranking system, gives NXTP stock a score of  27 out of a possible 100. That rank is chiefly influenced by a long-term technical score of 39. NXTP's rank also includes a short-term technical score of 41.  NXTP has

Nextplay Technologies Inc (NXTP) stock is down -27.52% over the last 12 months. InvestorsObserverâ€&#x2122;s proprietary ranking system, gives NXTP stock a score of  26 out of a possible 100. That rank is chiefly influenced by a short-term technical score of 34. NXTP's rank also includes a long-term technical score of 44.  NXTP has

Nextplay Technologies Inc (NXTP) Stock Is Lower By -11.48% This Week: Buy, Hold, or Sell?

NextPlay gets Nasdaq notice for listing non-compliance

RNLX, ASLN and SONN among pre-market losers

CLRO, SELX among major tech gainers; SPPL, BCAN among losers

ACAD

AIRE

AIRG

ALTO

AMLX

AMST

ANVS

ASLN

BCAN

BFRG

BLDE

BREA

BTDR

CERO

CLRO

CTMX

DWAC

FTFT

LGCL

LNVGY

NOTE

NXTP

ONON

PSQH

QBTS

RNLX

RVSN

SCKT

SELX

SONN

SPPL

SURGW

THTX

XPDB

Small Cap

Opinion

Press Releases

Thinking about buying stock in Shattuck Labs, Nextplay Technologies, PayPal, Zscaler, or Loop Media?

Comments

NextPlay Technologies

NextPlay Technologies (NXTP) Opzioni

No option chain data available. Please try again later

Notizie

PARTNER/COLLABORATORE

BENZINGA NEL MONDO